Stock listing
Frankfurt:S3F0 Santhera Pharmaceuticals Holding AG Aktie
German listing (Frankfurt) of Santhera Pharmaceuticals Holding AG · home listing SIX Swiss:SANN
Follow Santhera Pharmaceuticals Holding AG into a list and get an email when it puts out news.
Home listing price · SIX:SANN
15.04 CHF -0.28 (-1.8%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:SANN
- Day range
- 14.86 – 15.46 CHFNov 2, 2026
- Volume
- 107,584 sharesNov 2, 2026
- Market cap
- 230.4M CHFAt the close on Nov 2, 2026 · price × 15.32M shares outstanding
- 52-week range
- 10.06 – 18.84 CHFLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- 1.20M CHFMedian day 64,358 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:SANN · Home | 15.04 CHF | -0.28 (-1.8%) | 107,584 | 15.40 | 15.46 | 14.86 | 15.32 | Close on Nov 2, 2026 |
| LSE:0QN1 | 14.94 CHF | +0.32 (+2.2%) | 1,793 | 14.58 | 14.98 | 14.58 | 14.62 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · SIX:SANN · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 15.04 | -0.28 | -1.8% | 15.40 | 15.46 | 14.86 | 107,584 | |
| 15.32 | -0.28 | -1.8% | 15.58 | 15.58 | 15.12 | 51,276 | |
| 15.60 | +0.64 | +4.3% | 14.96 | 16.04 | 14.96 | 249,138 | |
| 14.96 | -0.10 | -0.7% | 15.32 | 15.46 | 14.46 | 117,054 | |
| 15.06 | +0.82 | +5.8% | 14.50 | 15.10 | 14.46 | 166,430 | |
| 14.24 | +0.40 | +2.9% | 14.00 | 14.72 | 13.94 | 67,826 | |
| 13.84 | -0.28 | -2.0% | 14.40 | 14.44 | 13.84 | 41,973 | |
| 14.12 | -0.70 | -4.7% | 14.70 | 14.72 | 14.12 | 19,740 | |
| 14.82 | +0.12 | +0.8% | 14.92 | 15.00 | 14.54 | 42,499 | |
| 14.70 | +0.28 | +1.9% | 14.28 | 14.84 | 14.28 | 59,098 | |
| 14.42 | 0.00 | 0.0% | 14.40 | 14.46 | 14.00 | 33,669 | |
| 14.42 | -0.18 | -1.2% | 14.60 | 14.64 | 14.34 | 32,000 | |
| 14.60 | +0.54 | +3.8% | 14.18 | 14.60 | 14.00 | 45,090 | |
| 14.06 | +0.36 | +2.6% | 13.78 | 14.18 | 13.42 | 66,249 | |
| 13.70 | -0.88 | -6.0% | 14.58 | 14.58 | 13.58 | 91,162 | |
| 14.58 | +0.30 | +2.1% | 14.24 | 14.62 | 14.24 | 27,118 | |
| 14.28 | +0.14 | +1.0% | 14.10 | 14.40 | 14.04 | 52,127 | |
| 14.14 | -0.54 | -3.7% | 14.48 | 14.60 | 14.14 | 94,070 | |
| 14.68 | -0.58 | -3.8% | 15.30 | 15.30 | 14.50 | 112,805 | |
| 15.26 | -0.22 | -1.4% | 15.42 | 15.98 | 15.04 | 77,318 | |
| 15.48 | +0.36 | +2.4% | 15.60 | 15.80 | 15.32 | 56,883 | |
| 15.12 | -0.06 | -0.4% | 15.48 | 15.52 | 15.10 | 78,002 | |
| 15.18 | -0.32 | -2.1% | 15.30 | 15.80 | 14.84 | 67,765 | |
| 15.50 | +0.42 | +2.8% | 15.20 | 15.58 | 14.68 | 165,560 | |
| 15.08 | +0.18 | +1.2% | 14.92 | 15.24 | 14.90 | 62,466 | |
| 14.90 | -0.32 | -2.1% | 15.36 | 15.44 | 14.90 | 106,453 | |
| 15.22 | +0.20 | +1.3% | 15.10 | 15.36 | 15.10 | 49,782 | |
| 15.02 | -0.42 | -2.7% | 15.50 | 15.50 | 15.02 | 59,981 | |
| 15.44 | -0.38 | -2.4% | 15.80 | 15.94 | 15.42 | 35,609 | |
| 15.82 | -0.28 | -1.7% | 16.10 | 16.16 | 15.76 | 33,132 | |
| 16.10 | +0.16 | +1.0% | 15.94 | 16.16 | 15.68 | 40,620 | |
| 15.94 | +0.20 | +1.3% | 15.86 | 16.28 | 15.80 | 73,757 | |
| 15.74 | -0.02 | -0.1% | 15.80 | 15.86 | 15.54 | 26,807 | |
| 15.76 | +0.18 | +1.2% | 15.70 | 15.80 | 15.38 | 42,094 | |
| 15.58 | +0.02 | +0.1% | 15.60 | 15.92 | 15.30 | 54,597 | |
| 15.56 | -0.20 | -1.3% | 15.76 | 15.88 | 15.46 | 54,923 | |
| 15.76 | -0.08 | -0.5% | 15.84 | 16.50 | 15.76 | 70,737 | |
| 15.84 | -0.42 | -2.6% | 16.50 | 16.50 | 15.78 | 58,592 | |
| 16.26 | -0.74 | -4.4% | 16.68 | 16.68 | 16.14 | 60,777 | |
| 17.00 | +1.54 | +10.0% | 15.42 | 17.00 | 15.38 | 165,085 | |
| 15.46 | -0.22 | -1.4% | 15.76 | 15.90 | 15.42 | 46,181 | |
| 15.68 | +0.06 | +0.4% | 15.70 | 15.86 | 15.42 | 51,146 | |
| 15.62 | +0.14 | +0.9% | 15.56 | 16.48 | 15.56 | 138,100 | |
| 15.48 | +0.54 | +3.6% | 14.88 | 15.80 | 14.80 | 73,450 | |
| 14.94 | +0.02 | +0.1% | 14.98 | 15.08 | 14.62 | 71,518 | |
| 14.92 | -0.50 | -3.2% | 15.28 | 15.40 | 14.90 | 89,471 | |
| 15.42 | -0.14 | -0.9% | 15.60 | 15.78 | 15.30 | 76,441 | |
| 15.56 | -0.10 | -0.6% | 15.78 | 15.90 | 15.48 | 51,901 | |
| 15.66 | -0.04 | -0.3% | 15.56 | 15.84 | 15.54 | 37,313 | |
| 15.70 | -0.28 | -1.8% | 15.98 | 16.26 | 15.52 | 61,802 | |
| 15.98 | -0.66 | -4.0% | 16.80 | 16.80 | 15.80 | 43,112 | |
| 16.64 | +0.12 | +0.7% | 16.58 | 16.80 | 16.18 | 28,097 | |
| 16.52 | -0.44 | -2.6% | 17.06 | 17.24 | 15.58 | 160,892 | |
| 16.96 | +0.46 | +2.8% | 16.42 | 17.10 | 16.42 | 131,440 | |
| 16.50 | +0.60 | +3.8% | 15.70 | 16.50 | 15.70 | 77,869 | |
| 15.90 | +0.04 | +0.3% | 15.88 | 16.04 | 15.68 | 26,420 | |
| 15.86 | -0.14 | -0.9% | 15.86 | 16.36 | 15.68 | 71,891 | |
| 16.00 | +0.12 | +0.8% | 15.98 | 16.02 | 15.78 | 30,851 | |
| 15.88 | -0.26 | -1.6% | 16.00 | 16.20 | 15.70 | 74,708 | |
| 16.14 | -0.26 | -1.6% | 16.48 | 16.90 | 16.10 | 114,540 | |
| 16.40 | +0.56 | +3.5% | 15.76 | 16.50 | 15.76 | 123,290 | |
| 15.84 | +0.34 | +2.2% | 15.50 | 16.00 | 15.50 | 140,872 | |
| 15.50 | +0.56 | +3.7% | 14.88 | 15.56 | 14.88 | 169,259 | |
| 14.94 | +0.88 | +6.3% | 14.10 | 15.06 | 14.10 | 210,602 | |
| 14.06 | +0.04 | +0.3% | 14.00 | 14.22 | 13.90 | 39,927 | |
| 14.02 | -0.14 | -1.0% | 14.12 | 14.24 | 13.86 | 73,526 |
- Ticker
- Frankfurt:S3F0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 23, 2026
Santhera’s Licensing Partner, Nxera Pharma, Submits Marketing Authorization Application for AGAMREE® (Vamorolone) in South Korea
Latest earnings call · Sep 30, 2026
Santhera Pharmaceuticals Holding (SIX Swiss: SANN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · October 2026
Proactive Investor Conference October 2026
Conference · 33 slides
Calls
Replays
Santhera Pharmaceuticals Holding (SIX Swiss: SANN) Q2 2026 Earnings Call
Wed, Sep 30, 2026 · 8:00 AM ET
Watch TranscriptSanthera Pharmaceuticals Holding (SIX Swiss: SANN) Q4 2025 Earnings Call
Tue, Apr 28, 2026 · 8:00 AM ET
Watch TranscriptSanthera Pharmaceuticals Holding (SIX Swiss: SANN) Q2 2025 Earnings Call
Tue, Sep 23, 2025 · 8:00 AM ET
Watch Transcript
Latest news
Santhera’s Licensing Partner, Nxera Pharma, Submits Marketing Authorization Application for AGAMREE® (Vamorolone) in South Korea
Oct 23, 2026
Closed 13.84 (-2.0%) on Oct 23, 2026
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
Jul 13, 2026
Closed 15.10 (-0.8%) on Jul 13, 2026
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea
Jun 2, 2026
Closed 15.20 (-3.8%) on Jun 2, 2026
Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
Apr 30, 2026
Closed 17.00 (-5.9%) on Apr 30, 2026
Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy
Apr 28, 2026
Closed 18.54 (+1.0%) on Apr 28, 2026
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
Apr 28, 2026
Closed 18.54 (+1.0%) on Apr 28, 2026
Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU
Apr 27, 2026
Closed 18.36 (+8.4%) on Apr 27, 2026
Santhera Appoints Orlando Oliveira as Chief Executive Officer
Apr 23, 2026
Closed 16.60 (-1.3%) on Apr 23, 2026
Full Year 2025 Trading Update
Mar 12, 2026
Closed 15.82 (-7.2%) on Mar 12, 2026
Santhera Appoints Marc Clausse as Chief Commercial Officer to Lead Next Phase of Growth
Mar 10, 2026
Closed 16.70 (+5.0%) on Mar 10, 2026
Decks
Proactive Investor Conference October 2026
Conference · 33 slides · October 2026
H1 2026 Earnings Presentation
Earnings · 35 slides · Sep 30, 2026
Investor Presentation (June 2026)
Investor deck · 36 slides · June 2026
Q4 2025 Earnings Presentation
Earnings · 29 slides · Apr 28, 2026
Santhera Pharmaceuticals Holding AG on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 18 in the last 12 months · 34 in all · newest Oct 23, 2026 · oldest 2025
- Calls
- 4 calls with a replay · 4 with a transcript · latest Sep 30, 2026
- Decks
- 18 decks · latest October 2026
Where Santhera Pharmaceuticals Holding AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:SANN · Home listing | SIX Swiss | Switzerland | CHF |
| OTC:SPHDF | OTC | United States | USD |
| LSE:0QN1 | LSE | United Kingdom | CHF |
| gettex:S3F0 | gettex | Germany | EUR |
| LS Exchange:A3EJMQ | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3EJMQ | Lang & Schwarz | Germany | EUR |
| Aquis:SANNZ | Aquis | United Kingdom | CHF |
| BX Swiss:S3F0 | BX Swiss | Switzerland | CHF |
| Tradegate:S3F0 | Tradegate | Germany | EUR |
| Dusseldorf:S3F0 | Dusseldorf | Germany | EUR |
| Frankfurt:S3F0 · This page | Frankfurt | Germany | EUR |
| Hamburg:S3F0 | Hamburg | Germany | EUR |
| Munich:S3F0 | Munich | Germany | EUR |
| Stuttgart:S3F0 | Stuttgart | Germany | EUR |
| Turquoise:SANNZ | Turquoise | United Kingdom | CHF |
Log in to ask 6ix AI your own questions about Santhera Pharmaceuticals Holding AG.